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“The Cardiovascular Manifestations of COVID-19: A Review of the Literature and Institutional
Experience”
Polsinelli GN, Korzeniewski SJ, Doubrovski OM, Paxton JH.
Department of Emergency Medicine, Wayne State University School of Medicine (Detroit, MI)

The cardiovascular health of those infected with severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) plays a major role in rates of hospitalization, mortality risk, and rates of mechanical
ventilation. In patients with COVID-19, acute myocardial injury and history of cardiovascular disease are
both independently established risk factors for poor patient prognosis. In addition to myocardial injury,
numerous acute cardiovascular manifestations of COVID-19 disease have been identified. Previous work
on this topic typically focused either upon a general description of the acute cardiovascular
manifestations and sequalae of COVID-19, or upon broad-based clinical outcomes associated with
COVID-19 in patients with history of cardiovascular and/or metabolic disease. However, the role of preexisting cardiovascular and metabolic disease in predicting the development and severity of COVID-19related cardiovascular complications remains unclear. We queried our institutional COVID-19 patient
registry, extracting data on all patients who were tested for the presence of SARS-CoV-2 and myocardial
injury from 3 March 2020 – 30 July 2020. We identified a total of 5,451 patients from our institutional
COVID-19 registry who met our criteria, including 734 (13.5%) subjects ultimately confirmed to be
COVID-19 positive, and 4,717 subjects confirmed to be COVID-19 negative. Those with a prior history of
cardiovascular disease can have increased frequency of cardiovascular manifestations. Cardiovascular
events in COVID-19 include acute myocardial injury, myocardial infarction, myocarditis, pericarditis,
electrocardiogram abnormalities, acute thrombosis, and acute heart failure. Identifying underlying
cardiovascular disease and evidence of myocardial injury may predict which patients should be
prioritized or potentially require more aggressive management and treatment strategies.
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